title: Premalignant variations in extracellular matrix composition in chemically induced hepatocellular carcinoma in rats.
abstract: Chemical composition of extracellular matrix (ECM) plays a pivotal role in cellular and tissue development, regeneration, and differentiation. It also plays a key role in pathogenesis of hepatocellular carcinoma (HCC). This study explored premalignant changes in the liver tissue content of collagen (as hydroxyproline, HP), total glycosaminoglycans (TGAGs), free glucosamine (FGA), total sialic acid (TSA), lysosomal membrane integrity variations (calculated as total and free cathepsin D activities), and liver histology. Serum alfa-fetoprotein (AFP) level was used as an early marker for HCC in two groups of Wistar rats. One group of rats served as control and was provided normal saline orally. The other group was provided trichloroacetic acid (TCA) as 0.5 g/kg/day for five consecutive days by oral gavage. Animals were killed before tumor development. The treatment revealed dysplastic changes in addition to microsteatosis (fatty changes). Both sinusoids and the portal vein among dysplastic cells were dilated and congested. These dysplastic foci are believed to be premalignant and may be precancerous lesions. The following things were observed: a highly significant increase in serum AFP (as a key marker for HCC), a significant decrease in HP and TSA, a significant increase in FGA, nonsignificant decrease in TGAGs, significant up-regulation of free cathepsin D, nonsignificant decrease in total cathepsin D activities, and destabilization of lysosomal membrane integrity. Down-regulation of HP, TSA, and TGAGs seems to be a prerequisite for cancer development. This might be stimulated by up-regulation of free cathepsin D activity. Perhaps tissue fibrosis is not a condition for developing HCC because collagen was significantly depressed. Up-regulated FGA could be assumed to be a defense mechanism against TCA-induced proteolysis of membrane proteins because it is frequently reported to be of value in cancer chemotherapy. Studied ECM perturbations can be assumed as preliminary changes during chemical hepatocarcinogenesis at the tissue level. Prospective studies on blood levels of cathepsins, TGAGs, and individual ECM variables such as TSA, FGA, and Hp in patients at risk for HCC, performed in parallel with assessments of AFP, may provide a cost-effective way to find new links between tissue changes and circulation that would permit early prediction of disease. It may also provide a way to monitor HCC and compensate for the missed peak AFP values.
authors.affiliation: Department of Biochemistry, College of Pharmacy, Minia University, Minia, Egypt. nabilmohie@yahoo.com
authors.forename: Nabil M
authors.initials: NM
authors.lastname: Abdel-Hamid
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000633:toxicity; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced* / Q000378:metabolism*; D002402:Cathepsin D; D004797:Enzyme-Linked Immunosorbent Assay; D005109:Extracellular Matrix / Q000737:chemistry* / Q000378:metabolism*; D005944:Glucosamine / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism; D006909:Hydroxyproline / Q000378:metabolism; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000378:metabolism*; D008297:Male; D019158:N-Acetylneuraminic Acid / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D014238:Trichloroacetic Acid / Q000633:toxicity*; D000509:alpha-Fetoproteins / Q000378:metabolism
chemical_list: D002273:Carcinogens; D006025:Glycosaminoglycans; D000509:alpha-Fetoproteins; D014238:Trichloroacetic Acid; D002402:Cathepsin D; D019158:N-Acetylneuraminic Acid; D005944:Glucosamine; D006909:Hydroxyproline
references.citation: J Gen Physiol. 1938 Sep 20;22(1):79-89
references.pmid: 19873094
references.citation: Mol Cells. 2006 Apr 30;21(2):224-8
references.pmid: 16682817
references.citation: Arch Biochem Biophys. 1961 May;93:440-7
references.pmid: 13786180
references.citation: J Clin Invest. 2001 Jul;108(2):169-73
references.pmid: 11457867
references.citation: Anal Biochem. 2000 Nov 1;286(1):149-55
references.pmid: 11038285
references.citation: Indian J Exp Biol. 2004 Aug;42(8):808-11
references.pmid: 15573532
references.citation: Bull Environ Contam Toxicol. 1983 Apr;30(4):394-9
references.pmid: 6850127
references.citation: Med Hypotheses. 2006;66(6):1115-20
references.pmid: 16504415
references.citation: Clin Chim Acta. 1973 Sep 28;48(1):15-8
references.pmid: 4201034
references.citation: Carcinogenesis. 1994 Oct;15(10):2255-61
references.pmid: 7955063
references.citation: Gastroenterology. 1998 Jan;114(1):139-52
references.pmid: 9428228
references.citation: Pharmazie. 2007 May;62(5):382-7
references.pmid: 17557749
references.citation: Clin Cancer Res. 2000 Feb;6(2):578-84
references.pmid: 10690542
references.citation: J Nucl Med. 1990 Oct;31(10):1654-8
references.pmid: 2213188
references.citation: Lab Invest. 2007 Sep;87(9):851-7
references.pmid: 17632542
references.citation: Reprod Nutr Dev. 1981;21(2):265-77
references.pmid: 6760290
references.citation: C R Acad Hebd Seances Acad Sci D. 1978 May 22;286(20):1483-5
references.pmid: 27317
references.citation: Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):571-7
references.pmid: 15618547
references.citation: Carcinogenesis. 1995 Mar;16(3):495-500
references.pmid: 7697804
references.citation: Toxicol Appl Pharmacol. 1987 Apr;88(2):225-33
references.pmid: 3564041
references.citation: Prog Drug Res. 2000;55:81-103
references.pmid: 11127967
references.citation: J Cell Sci. 1967 Dec;2(4):499-512
references.pmid: 4169931
references.citation: Environ Health Perspect. 1986 Nov;69:73-9
references.pmid: 2880713
references.citation: J Biol Chem. 1950 May;184(1):299-306
references.pmid: 15421999
references.citation: J Biol Chem. 1975 Aug 10;250(15):6151-9
references.pmid: 125282
references.citation: Clin Exp Pharmacol Physiol. 2008 Oct;35(10):1190-6
references.pmid: 18565195
references.citation: Nat Med. 1999 Jul;5(7):793-802
references.pmid: 10395325
references.citation: Clin Chim Acta. 2003 Jan;327(1-2):139-47
references.pmid: 12482629
references.citation: Neoplasia. 2006 Apr;8(4):312-8
references.pmid: 16756723
references.citation: Biochem J. 1967 Jan;102(1):367-72
references.pmid: 6030295
references.citation: J Pharm Pharmacol. 1996 Apr;48(4):437-40
references.pmid: 8794998
references.citation: Annu Rev Cell Biol. 1993;9:541-73
references.pmid: 8280471
references.citation: Semin Cancer Biol. 2002 Jun;12(3):243-57
references.pmid: 12083854
references.citation: Cancer Res. 2005 Jul 15;65(14):6245-54
references.pmid: 16024626
references.citation: Nat Med. 1999 Jul;5(7):803-9
references.pmid: 10395326
references.citation: Z Naturforsch C J Biosci. 2004 Nov-Dec;59(11-12):897-900
references.pmid: 15666553
references.citation: Exp Toxicol Pathol. 1997 Dec;49(5):369-73
references.pmid: 9455684
references.citation: Curr Opin Chem Biol. 2000 Dec;4(6):626-31
references.pmid: 11102866
references.citation: Br Poult Sci. 1993 Sep;34(4):819-24
references.pmid: 8242418
references.citation: J Biol Chem. 1957 May;226(1):497-509
references.pmid: 13428781
references.citation: Cancer Res. 1973 Mar;33(3):613-7
references.pmid: 4120353
references.citation: J Biol Chem. 1959 Aug;234(8):1971-5
references.pmid: 13672998
references.citation: Cancer. 2000 Dec 1;89(11):2282-91
references.pmid: 11147599
references.citation: Poult Sci. 2002 Jan;81(1):92-4
references.pmid: 11885906
references.citation: Diabetologia. 1988 Feb;31(2):119-22
references.pmid: 3282952
references.citation: J Zhejiang Univ Sci B. 2006 Aug;7(8):608-14
references.pmid: 16845712
references.citation: Biochem J. 1933;27(6):1824-8
references.pmid: 16745305
references.citation: Acta Pharmacol Sin. 2007 Sep;28(9):1331-42
references.pmid: 17723167
references.citation: Anal Biochem. 1979 Oct 15;99(1):183-8
references.pmid: 532958
references.citation: Cancer. 1992 Jul 1;70(1):45-9
references.pmid: 1318778
references.citation: Mol Cancer Res. 2007 Jan;5(1):21-33
references.pmid: 17259344
references.citation: Toxicol Lett. 1995 Oct;80(1-3):97-104
references.pmid: 7482597
references.citation: Cell Signal. 1998 Jan;10(1):1-11
references.pmid: 9502112
references.citation: Arch Environ Contam Toxicol. 1988 Jul;17(4):429-36
references.pmid: 3408265
references.citation: Hepatology. 2005 Apr;41(4):857-67
references.pmid: 15726641
references.citation: World J Gastroenterol. 2005 Oct 28;11(40):6269-76
references.pmid: 16419154
references.citation: Toxicol Appl Pharmacol. 1985 Jul;79(3):365-76
references.pmid: 4035684
references.citation: Cancer Chemother Pharmacol. 1985;15(1):26-30
references.pmid: 4006046
references.citation: J Toxicol Environ Health A. 2008;71(16):1056-68
references.pmid: 18569617
references.citation: Toxicol Sci. 2000 Apr;54(2):399-407
references.pmid: 10774822
references.citation: Eur Surg Res. 2007;39(3):136-40
references.pmid: 17337890
references.citation: FASEB J. 1995 Nov;9(14):1401-10
references.pmid: 7589981
references.citation: Toxicology. 1990 Oct;64(1):71-80
references.pmid: 2219134
references.citation: J Ayub Med Coll Abbottabad. 2005 Jul-Sep;17(3):54-7
references.pmid: 16320799
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713